BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3921238)

  • 21. An in vivo model of prostate carcinoma growth and invasion in bone.
    Fisher JL; Schmitt JF; Howard ML; Mackie PS; Choong PF; Risbridger GP
    Cell Tissue Res; 2002 Mar; 307(3):337-45. PubMed ID: 11904770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental model for studying the invasive characteristics of malignant tumours transplanted in bone and muscle of rats.
    Magrassi B
    Ital J Orthop Traumatol; 1976 Dec; 2(3):383-91. PubMed ID: 1031415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ethane-1-hydroxy-1, 1-diphosphonate on cell differentiation, and proteoglycan and calcium metabolism, in the proximal tibia of young rats.
    Katoh Y; Tsuji H; Matsui H; Maruta K; Morita Y
    Bone; 1991; 12(2):59-65. PubMed ID: 1905942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
    Cohen-Solal ME; Bouizar Z; Denne MA; Graulet AM; Gueris J; Bracq S; Jullienne A; de Vernejoul MC
    Horm Metab Res; 1995 Sep; 27(9):403-7. PubMed ID: 8557238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a murine model of bone invasion by oral squamous cell carcinoma.
    Nomura T; Shibahara T; Katakura A; Matsubara S; Takano N
    Oral Oncol; 2007 Mar; 43(3):257-62. PubMed ID: 16920384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL; Pathak S; Multani AS; Price JE
    J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of tumor formation by snake venom disintegrin.
    Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM
    Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia.
    Zhang RX; Liu B; Wang L; Ren K; Qiao JT; Berman BM; Lao L
    Pain; 2005 Nov; 118(1-2):125-36. PubMed ID: 16154703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased bone calcium following endurance exercise in the mature female rat.
    Darby LA; Pohlman RL; Lechner AJ
    Lab Anim Sci; 1985 Aug; 35(4):382-6. PubMed ID: 4046548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice.
    Nemoto R; Kanoh S; Koiso K; Harada M
    J Urol; 1988 Oct; 140(4):875-9. PubMed ID: 3138435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells.
    Hashii K; Tohya K; Kimura M; Tateyama I; Mori T; Kadota E; Hashimoto S; Tomura T
    Invasion Metastasis; 1997; 17(3):149-57. PubMed ID: 9702941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
    Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing growth and response to therapy in murine tumor models.
    Reynolds CP; Sun BC; DeClerck YA; Moats RA
    Methods Mol Med; 2005; 111():335-50. PubMed ID: 15911989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypercalcemic activity of Walker carcinosarcoma 256 in the rat].
    Minne H; Ziegler R; Schmitt W; Hilgard P
    Schweiz Med Wochenschr; 1971 Apr; 101(13):481-3. PubMed ID: 5558917
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
    Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
    Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
    Alvarez E; Westmore M; Galvin RJ; Clapp CL; Considine EL; Smith SJ; Keyes K; Iversen PW; Delafuente DM; Sulaimon S; Zambrano C; Ma L; Sato M; Martin TJ; Teicher BA; Galbreath EJ
    Clin Cancer Res; 2003 Nov; 9(15):5705-13. PubMed ID: 14654555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Bone Cancer Pain Induced by Different Doses of Walker 256 Mammary Gland Carcinoma Cells.
    Dong C; Wu R; Wu J; Guo J; Wang F; Fu Y; Wang Q; Xu L; Wang J
    Pain Physician; 2016; 19(7):E1063-77. PubMed ID: 27676678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
    Zheng Y; Zhou H; Modzelewski JR; Kalak R; Blair JM; Seibel MJ; Dunstan CR
    Cancer Res; 2007 Oct; 67(19):9542-8. PubMed ID: 17909065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.